Shareholder alert: robbins llp reminds investors that provention bio, inc. (prvb) is being sued for misleading shareholders

San diego & red bank, n.j.--(business wire)---- $prvb #classaction--shareholder rights law firm robbins llp reminds investors that a class action has been filed on behalf of all purchasers of provention bio, inc. (nasdaq: prvb) securities between november 2, 2020 and april 8, 2021, against the company and certain of its officers for remedies under the securities exchange act of 1934. provention is a clinical stage biopharmaceutical company that focuses on the development and commercialization of therapeutics and solu
PRVB Ratings Summary
PRVB Quant Ranking